Vaccinia Virus Protein C6 Is a Virulence Factor that Binds TBK-1 Adaptor Proteins and Inhibits Activation of IRF3 and IRF7
2011

Vaccinia Virus Protein C6 Inhibits Immune Response

publication 10 minutes Evidence: high

Author Information

Author(s): Leonie Unterholzner, Rebecca P. Sumner, Marcin Baran, Hongwei Ren, Daniel S. Mansur, Nollaig M. Bourke, Felix Randow, Geoffrey L. Smith, Andrew G. Bowie

Primary Institution: Trinity College Dublin

Hypothesis

Does the vaccinia virus protein C6 inhibit the activation of immune response factors IRF3 and IRF7?

Conclusion

The study found that the vaccinia virus protein C6 inhibits the activation of immune response factors IRF3 and IRF7, contributing to the virus's virulence.

Supporting Evidence

  • C6 was identified as an inhibitor of IFN-β expression through a functional screen.
  • C6 prevents the nuclear translocation of IRF3 and IRF7.
  • Viruses lacking C6 were attenuated in vivo compared to wild type.
  • C6 interacts with TBK1 scaffold proteins without disrupting their function.

Takeaway

The C6 protein from the vaccinia virus helps the virus avoid detection by the immune system, making it more dangerous.

Methodology

The study used a functional screen of vaccinia virus proteins to identify those that inhibit type I IFN induction, followed by various assays to measure the effects of C6 on immune signaling.

Limitations

The study primarily focused on in vitro assays and may not fully represent in vivo conditions.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.ppat.1002247

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication